Clinical Trial Update: A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 bioavailability study of Sebacoyl Dinalbuphine Ester administered by intramuscular injection in healthy volunteers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Sebacoyl Dinalbuphine Ester IM Injection (Sebacoyl dinalbuphine ester)

Snippet

Sponsor: Lumosa Therapeutics Co., Ltd. | Conditions: Pain, Analgesia Disorder | Phase 1 | Status: COMPLETED